Qube Research & Technologies (QRT)’s Cogent Biosciences COGT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.55M	Sell	169,198 -224,802	-57%	-$7.87M	0.01%	1498
2026 Q1	$15.2M	Buy	394,000 +117,272	+42%	+$4.33M	0.02%	1035
2025 Q4	$9.83M	Buy	276,728 +163,070	+143%	+$4.58M	0.01%	1355
2025 Q3	$1.63M	Buy	113,658 +94,756	+501%	+$1.12M	﹤0.01%	2326
2025 Q2	$136K	Buy	+18,902	New	+$105K	﹤0.01%	2984
2024 Q2	–	Sell	-123,017	Closed	-$827K	–	3923
2024 Q1	$827K	Buy	123,017 +5,849	+5%	+$36.2K	﹤0.01%	2255
2023 Q4	$689K	Buy	+117,168	New	+$898K	﹤0.01%	2119
2021 Q4	–	Sell	-38,213	Closed	-$321K	–	2582
2021 Q3	$321K	Sell	38,213 -17,374	-31%	-$133K	﹤0.01%	1458
2021 Q2	$451K	Buy	55,587 +6,546	+13%	+$55.3K	0.01%	1338
2021 Q1	$431K	Buy	+49,041	New	+$472K	0.01%	1266

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Qube Research & Technologies (QRT)'s COGT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cogent Biosciences (COGT) stake by 57% in Q2 2026, selling an estimated $7.87M and leaving 169,198 shares worth $6.55M. The position accounts for 0.01% of the portfolio, ranked #1498.

Qube Research & Technologies (QRT) first reported a position in COGT in Q1 2021 and has held it in 10 quarters since. The position peaked at $15.2M in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Qube Research & Technologies (QRT) held 169,198 shares of Cogent Biosciences worth $6.55M as of Q2 2026.
Qube Research & Technologies (QRT) sold 224,802 Cogent Biosciences shares in Q2 2026, an estimated $7.87M.
Cogent Biosciences made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1498 holding.
Qube Research & Technologies (QRT) first reported a position in Cogent Biosciences in Q1 2021 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Cogent Biosciences position peaked at $15.2M in Q1 2026.
323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.